7 Results for "

AMG510

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "AMG510" in MCE Product Catalog:

121
121 Cited Publications
Cat. No.: HY-114277
CAS No.: 2296729-00-3
Purity:  99.94%
Synonyms: AMG-510
Target:  

Ras

Research Areas:  

Cancer

Sotorasib (AMG-510) is a first-in-class, orally bioavailable, and selective KRAS G12C covalent inhibitor. Sotorasib irreversibly inhibits KRAS G12C by locking it in an inactive GDP-bound state. Sotorasib leads to the regression of KRAS G12C‑mutated locally advanced or metastatic non‑small cell lung cancer (NSCLC) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-114277A
CAS No.: 2252403-56-6
Purity:  98.99%
Synonyms: AMG-510 racemate
Target:  

Ras p38 MAPK

Research Areas:  

Cancer

Sotorasib racemate (Compound A) is an orally active racemate of Sotorasib (HY-114277), a covalent inhibitor of KRAS G12C mutant which induces adaptive feedback activation of MAPK pathway. Sotorasib racemate also exerts inhibitor activity against KRAS G12C induced cancer and can be applied to cancer research .
loading...
    loading...
Cat. No.: HY-114277B
Purity:  99.09%
Synonyms: AMG-510 isomer
Target:  

Ras

Research Areas:  

Others

Sotorasib (AMG-510) isomer is the less active isomer of Sotorasib (AMG-510). AMG-510 is a potent KRAS G12C covalent inhibitor.
loading...
    loading...
Cat. No.: HY-114277R
CAS No.: 2296729-00-3
Synonyms: AMG-510 (Standard)
Target:  

Ras Reference Standards

Research Areas:  

Cancer

Sotorasib (Standard) is the analytical standard of Sotorasib. This product is intended for research and analytical applications. Sotorasib (AMG-510) is a first-in-class, orally bioavailable, and selective KRAS G12C covalent inhibitor. Sotorasib irreversibly inhibits KRAS G12C by locking it in an inactive GDP-bound state. Sotorasib leads to the regression of KRAS G12C‑mutated locally advanced or metastatic non‑small cell lung cancer (NSCLC) .
loading...
    loading...
Cat. No.: HY-114277S
Purity:  98.90%
Synonyms: AMG-510-d7
Sotorasib-d7 (AMG-510-d7) is a deuterium-labeled Sotorasib (HY-114277). Sotorasib (AMG-510) is a first-in-class, orally bioavailable, and selective KRAS G12C covalent inhibitor. Sotorasib irreversibly inhibits KRAS G12C by locking it in an inactive GDP-bound state. Sotorasib leads to the regression of KRAS G12C‑mutated locally advanced or metastatic non‑small cell lung cancer (NSCLC) .
loading...
    loading...
Cat. No.: HY-114277S2
Synonyms: AMG-510-d3
Sotorasib-d3 (AMG-510-d3) is deuterium labeled Sotorasib. Sotorasib (AMG-510) is a first-in-class, orally bioavailable, and selective KRAS G12C covalent inhibitor. Sotorasib irreversibly inhibits KRAS G12C by locking it in an inactive GDP-bound state. Sotorasib leads to the regression of KRAS G12C?mutated locally advanced or metastatic non?small cell lung cancer (NSCLC) .
loading...
    loading...
Cat. No.: HY-114277BS
Synonyms: AMG-510-d7 isomer
Sotorasib-d7 isomer (AMG-510-d7 isomer) is the deuterium labeled Sotorasib isomer.
loading...
    loading...